Chronic Fatigue Syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Have been diagnosed with COVID-19 in the previous period of at least 6 months;Be identified with Chronic Fatigue Syndrome through the International Consensus Criteria; be able to perform physical exercise based on the Physical Activity Readiness Questionnaire (PAR-Q); adult patients (aged 18 years or older); be a consumer of low to moderate amounts of caffeine (200-400mg daily); be literate
Exclusion criteria
Exclusion criteria: Results on the Electrocardiogram that identify incompatibility with the performance of physical exercises; musculoskeletal pathologies that prevent participation; moderate to severe cardiovascular disorders; convulsive history;Gastric problems;Use of nutritional supplements or ergogenic aids; structural or functional deformities;Ischemic or hemorrhagic stroke; arterial hypertension; neurodegenerative diseases; cognitive problems; visual disturbances without treatment; gestation; use of oral contraceptives; color blindness; smoking; use tricyclic antidepressants; use of medications containing caffeine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a decrease in persistent symptoms of physical and mental fatigue resulting from Chronic Fatigue Syndrome due to the use of 3mg/kg of caffeine, verified by physical test methods involving cardiorespiratory fitness and muscle strength, psychological test involving concentration and attention and control variables such as heart rate, respiratory rate, blood pressure and oxygen saturation.;It is expected to diagnose the Chronic Fatigue Syndrome through the Myalgic Encephalomyelitis Scale - International Consensus Criteria that describes the symptoms caused by the syndrome. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that volunteers have a significant improvement in quality of life, return to work and activities of daily living, consequently increasing functional independence and decreasing susceptibility to depression due to caffeine treatment. This information will be evaluated through a questionnaire. | — |
Countries
Brazil
Contacts
Universidade Federal de Santa Catarina